Ontario Ramping up Capacity in Preparation of Vaccinating Phase Two Populations

Published on February 22, 2021

The government has administered more than half a million doses of the COVID-19 vaccines to Phase One priority populations, which now includes adults 80 years of age and older. Ontario has administered more vaccines than any other province.

The unexpected reductions in supply and delayed shipments from the federal government forced Ontario to quickly adjust its vaccination plan to accelerate its focus on vaccinating the province’s highest risk resident populations. Last week, Ontario reached its target to offer a first dose of the vaccine to residents of all long-term care homes across the province.

When all reasonable steps have been taken to complete first-dose vaccinations of all staff, essential caregivers and residents of long-term care, high-risk retirement homes and First Nations elder care homes, first-dose vaccinations will be made available, pending supply, to the remainder of Phase One populations, including those ages 80+. 

We know Ontarians are eager to receive this layer of protection, and we are ready to ramp up our efforts as we receive more doses from the federal government.

The province is working with public health units to build and expand its capacity to immunize Phase Two populations by increasing delivery networks and developing an IT portal to support mass vaccinations. Phase Two vaccinations are expected to begin in April 2021.

Operation Remote Immunity, led by Ornge, is vaccinating adults in the 31 fly-in First Nations communities and Moosonee in Northern Ontario. As of February 17, 2021, over 8,000 doses of the vaccine have been administered in Sioux Lookout and communities within the Operation’s scope.

As the vaccination rollout continues, it remains critically important that all Ontarians stay at home as much as possible and continue following regional public health measures, restrictions, and advice to protect our most vulnerable populations and help stop the spread of COVID-19.

For News Release, click here